An observational study in Subarachnoid Hemorrhage and Intracranial Arteriovenous Malformation, sponsored by University Hospital, Bonn. Status unknown at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-12-11.
Sponsored by University Hospital, Bonn · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 37 studies in Subarachnoid Hemorrhage with a site in Germany — 2 open to participants now, 3 under way, none of them phase 3. Subarachnoid Hemorrhage · Germany.
Among the 37 studies in Subarachnoid Hemorrhage with a site in Germany, this one is the 16th largest by planned enrollment of the 16 observational ones that give a count, is one of 4 that started in 2014, is one of 16 observational ones, and was the 19th registered.
510 studies on the registry are indexed under Subarachnoid Hemorrhage; 128 are open to participants now.
Browse Subarachnoid Hemorrhage studies →2 of the 37 studies in Subarachnoid Hemorrhage with a site in Germany are open now. Recruiting first, the newest first:
BDH-Klinik Hessisch Oldendorf · Sites in Germany
Ages 18–70
University Hospital, Essen · Sites in Germany
Ages 18+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 89 Subarachnoid Hemorrhage studies recruiting now, 56 (63%) set no upper age limit and 4 (4%) stop at 75 or younger; 7 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
37 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 4 started in 2014.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 12 is below the median of 120 across 226 observational studies indexed under Subarachnoid Hemorrhage.
Median enrollment 108 across the 21 interventional studies, 100 across the 16 observational. Of the 19 that completed or were terminated, 2 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 37 have an industry lead sponsor. The 10 most frequent:
University Hospital, Bonn is the lead sponsor of 154 studies on the registry; 28 are open to participants now.
University Hospital, Bonn has 4 studies filed under Subarachnoid Hemorrhage — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 37 studies in Subarachnoid Hemorrhage with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Near infrared spectroscopy is a valuable tool to monitor cerebral oxygenation during intracranial interventions. However, it yields artificial results when the dye indocyanine green (ICG) is applied, which is routinely done for intraoperative angiography.
The investigators examine, to what extent and which duration NIRS is disturbed following ICG application.
Patients undergoing cerebral aneurysm clipping or av-malformation removal
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
amount of rSO2 - change [%] induced by ICG-application
Cerebral oxygenation (rSO2) may be quantified using NIRS. The dye ICG, that is used intraoperatively, affects NIRS, since it changes rSO2 without modifying cerebral oxygenation. The amount, by which rSO2 is altered will be assessed
Time frame: 1 hour
The record gives a start of Mar 2014, a primary completion of Jan 2018 and a completion of Mar 2018. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.